155 related articles for article (PubMed ID: 19079660)
1. The Differential Effects of R580A Mutation on Transamidation and GTP Binding Activity of Rat and Human Type 2 Transglutaminase.
Ruan Q; Tucholski J; Gundemir S; Johnson Voll GV
Int J Clin Exp Med; 2008; 1(3):248-59. PubMed ID: 19079660
[TBL] [Abstract][Full Text] [Related]
2. Mutation of a critical arginine in the GTP-binding site of transglutaminase 2 disinhibits intracellular cross-linking activity.
Begg GE; Holman SR; Stokes PH; Matthews JM; Graham RM; Iismaa SE
J Biol Chem; 2006 May; 281(18):12603-9. PubMed ID: 16522628
[TBL] [Abstract][Full Text] [Related]
3. Cytosolic guanine nucledotide binding deficient form of transglutaminase 2 (R580a) potentiates cell death in oxygen glucose deprivation.
Colak G; Keillor JW; Johnson GV
PLoS One; 2011 Jan; 6(1):e16665. PubMed ID: 21304968
[TBL] [Abstract][Full Text] [Related]
4. Intracellular localization and conformational state of transglutaminase 2: implications for cell death.
Gundemir S; Johnson GV
PLoS One; 2009 Jul; 4(7):e6123. PubMed ID: 19568436
[TBL] [Abstract][Full Text] [Related]
5. External GTP-bound transglutaminase 2 is a molecular switch for chondrocyte hypertrophic differentiation and calcification.
Johnson KA; Terkeltaub RA
J Biol Chem; 2005 Apr; 280(15):15004-12. PubMed ID: 15691824
[TBL] [Abstract][Full Text] [Related]
6. Using FLIM-FRET to measure conformational changes of transglutaminase type 2 in live cells.
Caron NS; Munsie LN; Keillor JW; Truant R
PLoS One; 2012; 7(8):e44159. PubMed ID: 22952912
[TBL] [Abstract][Full Text] [Related]
7. Functional characterization of naturally occurring transglutaminase 2 mutants implicated in early-onset type 2 diabetes.
Salter NW; Ande SR; Nguyen HK; Nyomba BL; Mishra S
J Mol Endocrinol; 2012 Jun; 48(3):203-16. PubMed ID: 22394545
[TBL] [Abstract][Full Text] [Related]
8. Competitive Binding of Magnesium to Calcium Binding Sites Reciprocally Regulates Transamidase and GTP Hydrolysis Activity of Transglutaminase 2.
Jeong EM; Lee KB; Kim GE; Kim CM; Lee JH; Kim HJ; Shin JW; Kwon MA; Park HH; Kim IG
Int J Mol Sci; 2020 Jan; 21(3):. PubMed ID: 31991788
[TBL] [Abstract][Full Text] [Related]
9. Role of Tissue Transglutaminase Catalytic and Guanosine Triphosphate-Binding Domains in Renal Cell Carcinoma Progression.
Ulukan B; Bihorac A; Sipahioglu T; Kiraly R; Fesus L; Telci D
ACS Omega; 2020 Nov; 5(43):28273-28284. PubMed ID: 33163811
[TBL] [Abstract][Full Text] [Related]
10. Probing tissue transglutaminase mediated vascular smooth muscle cell aging using a novel transamidation-deficient Tgm2-C277S mouse model.
Wang H; Chen J; Jandu S; Melucci S; Savage W; Nandakumar K; Kang SK; Barreto-Ortiz S; Poe A; Rastogi S; Bauer M; Steppan J; Santhanam L
Cell Death Discov; 2021 Jul; 7(1):197. PubMed ID: 34326316
[TBL] [Abstract][Full Text] [Related]
11. Transglutaminase in Receptor and Neurotransmitter-Regulated Functions.
Muma NA
Med One; 2018; 3(6):. PubMed ID: 30701197
[TBL] [Abstract][Full Text] [Related]
12. Structural basis for the guanine nucleotide-binding activity of tissue transglutaminase and its regulation of transamidation activity.
Liu S; Cerione RA; Clardy J
Proc Natl Acad Sci U S A; 2002 Mar; 99(5):2743-7. PubMed ID: 11867708
[TBL] [Abstract][Full Text] [Related]
13. Identification of DNAJA1 as a novel interacting partner and a substrate of human transglutaminase 2.
Ergülen E; Bécsi B; Csomós I; Fésüs L; Kanchan K
Biochem J; 2016 Nov; 473(21):3889-3901. PubMed ID: 27551108
[TBL] [Abstract][Full Text] [Related]
14. Identification of a specific one amino acid change in recombinant human transglutaminase 2 that regulates its activity and calcium sensitivity.
Kanchan K; Ergülen E; Király R; Simon-Vecsei Z; Fuxreiter M; Fésüs L
Biochem J; 2013 Nov; 455(3):261-72. PubMed ID: 23941696
[TBL] [Abstract][Full Text] [Related]
15. Type 2 transglutaminase differentially modulates striatal cell death in the presence of wild type or mutant huntingtin.
Ruan Q; Quintanilla RA; Johnson GV
J Neurochem; 2007 Jul; 102(1):25-36. PubMed ID: 17403029
[TBL] [Abstract][Full Text] [Related]
16. Isopeptidase activity of human transglutaminase 2: disconnection from transamidation and characterization by kinetic parameters.
Király R; Thangaraju K; Nagy Z; Collighan R; Nemes Z; Griffin M; Fésüs L
Amino Acids; 2016 Jan; 48(1):31-40. PubMed ID: 26250429
[TBL] [Abstract][Full Text] [Related]
17. Inhibition or ablation of transglutaminase 2 impairs astrocyte migration.
Monteagudo A; Ji C; Akbar A; Keillor JW; Johnson GVW
Biochem Biophys Res Commun; 2017 Jan; 482(4):942-947. PubMed ID: 27899316
[TBL] [Abstract][Full Text] [Related]
18. Transglutaminase 2 in neurodegenerative disorders.
Ruan Q; Johnson GV
Front Biosci; 2007 Jan; 12():891-904. PubMed ID: 17127346
[TBL] [Abstract][Full Text] [Related]
19. Modulation of the in situ activity of tissue transglutaminase by calcium and GTP.
Zhang J; Lesort M; Guttmann RP; Johnson GV
J Biol Chem; 1998 Jan; 273(4):2288-95. PubMed ID: 9442073
[TBL] [Abstract][Full Text] [Related]
20. Monitoring of transglutaminase 2 under different oxidative stress conditions.
Caccamo D; Currò M; Ferlazzo N; Condello S; Ientile R
Amino Acids; 2012 Feb; 42(2-3):1037-43. PubMed ID: 21805137
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]